Alternatively, in a personalized medicine approach, patients with systemic hypertension and glaucoma could choose ARBs instead of, or in addition to, angiotensin converting enzyme inhibitors to treat hypertension while receiving additional benefits for treating glaucoma. Here, ACE is linked to glaucoma.